Skip to main content

Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial

Publication ,  Journal Article
Hylek, EM; Held, C; Alexander, JH; Lopes, RD; DeCaterina, R; Huber, K; Jansky, P; Steg, G; Hanna, M; Wallentin, L; Granger, C
Published in: CIRCULATION
November 20, 2012

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 20, 2012

Volume

126

Issue

21

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hylek, E. M., Held, C., Alexander, J. H., Lopes, R. D., DeCaterina, R., Huber, K., … Granger, C. (2012). Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial. CIRCULATION, 126(21).
Hylek, Elaine M., Claes Held, John H. Alexander, Renato D. Lopes, Raffaele DeCaterina, Kurt Huber, Petr Jansky, et al. “Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial.” CIRCULATION 126, no. 21 (November 20, 2012).
Hylek EM, Held C, Alexander JH, Lopes RD, DeCaterina R, Huber K, et al. Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial. CIRCULATION. 2012 Nov 20;126(21).
Hylek, Elaine M., et al. “Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial.” CIRCULATION, vol. 126, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2012.
Hylek EM, Held C, Alexander JH, Lopes RD, DeCaterina R, Huber K, Jansky P, Steg G, Hanna M, Wallentin L, Granger C. Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2012 Nov 20;126(21).

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 20, 2012

Volume

126

Issue

21

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology